NCCN practice guidelines for multiple myeloma

ONCOLOGY

Volumn 12, Issue 11 A, 1998, Pages 317-351

  Anderson, K C ^a   Bensinger, W ^a   Bernstein, S ^a   Biermann, S ^a   Meredith, R ^a   Michaeli, J ^a   Noga, S J ^a   Stockerl Goldstein, K ^a   Traynor, A ^a   Weber, D ^a   Yahalom, J ^a  

^a NCCN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; DEXAMETHASONE; FLUDARABINE; MELPHALAN; NUCLEOSIDE; PREDNISONE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; STEROID; VINCRISTINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; AMYLOIDOSIS; CLINICAL FEATURE; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; FOLLOW UP; HUMAN; LABORATORY TEST; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRACTICE GUIDELINE; SALVAGE THERAPY; TREATMENT INDICATION; TREATMENT PLANNING;

AMYLOIDOSIS; BONE DISEASES; DECISION TREES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MULTIPLE MYELOMA; NEOPLASM STAGING; WALDENSTROM MACROGLOBULINEMIA;

EID: 0032421630     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)